Stomach cancer
mmunotherapy and Radiation in Operable Gastric Cancers
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine and radiation and surgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial HospitalMumbaiDirections ↗
Registry summary (technical)
Phase 2 study evaluating the addition of immune-sensitizing radiotherapy and biomarker-driven low-dose nivolumab in locally advanced resectable gastroesophageal junction/gastric cancers - NISaRGA
Sponsor: Tata Memorial Hospital
CTRI/2025/02/079994 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 5 Oct 2026 · read by us 5 Nov 2026